News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
141,314 Results
Type
Article (5405)
Company Profile (45)
Press Release (135857)
Section
Business (49545)
Career Advice (130)
Deals (8312)
Drug Delivery (7)
Drug Development (17753)
Employer Resources (20)
FDA (3059)
Job Trends (3624)
News (76617)
Policy (5661)
Tag
Academia (405)
Accelerated approval (4)
Adcomms (1)
Allergies (27)
Alliances (6078)
ALS (20)
Alzheimer's disease (437)
Antibody-drug conjugate (ADC) (61)
Approvals (3180)
Artificial intelligence (46)
Autoimmune disease (24)
Automation (5)
Bankruptcy (52)
Best Places to Work (3334)
BIOSECURE Act (1)
Biosimilars (34)
Biotechnology (35)
Bladder cancer (58)
Brain cancer (8)
Breast cancer (161)
Cancer (1017)
Cardiovascular disease (84)
Career advice (113)
CAR-T (35)
CDC (3)
Cell therapy (109)
Cervical cancer (8)
Clinical research (15608)
Collaboration (158)
Company closure (1)
Compensation (124)
Complete response letters (6)
COVID-19 (499)
CRISPR (8)
C-suite (61)
Cystic fibrosis (32)
Data (1476)
Depression (21)
Diabetes (100)
Diagnostics (1522)
Digital health (10)
Diversity (1)
Diversity, equity & inclusion (3)
Drug discovery (28)
Drug pricing (12)
Drug shortages (2)
Duchenne muscular dystrophy (58)
Earnings (38668)
Editorial (4)
Employer branding (6)
Employer resources (15)
Events (22457)
Executive appointments (67)
FDA (3814)
Fibrodysplasia Ossificans Progressiva (2)
Frontotemporal dementia (6)
Funding (176)
Gene editing (21)
Generative AI (4)
Gene therapy (70)
GLP-1 (223)
Government (786)
Grass and pollen (2)
Guidances (300)
Healthcare (4686)
HIV (17)
Huntington's disease (8)
IgA nephropathy (17)
Immunology and inflammation (41)
Immuno-oncology (6)
Indications (21)
Infectious disease (538)
Inflammatory bowel disease (38)
Inflation Reduction Act (3)
Influenza (23)
Intellectual property (33)
Interviews (12)
IPO (5419)
IRA (4)
Job creations (422)
Job search strategy (105)
Kidney cancer (6)
Labor market (19)
Layoffs (120)
Leadership (3)
Legal (1055)
Liver cancer (19)
Longevity (1)
Lung cancer (159)
Lymphoma (109)
Machine learning (1)
Management (6)
Manufacturing (75)
MASH (52)
Medical device (3386)
Medtech (3396)
Mergers & acquisitions (3084)
Metabolic disorders (251)
Multiple sclerosis (39)
NASH (4)
Neurodegenerative disease (42)
Neuropsychiatric disorders (20)
Neuroscience (647)
NextGen: Class of 2025 (1066)
Non-profit (832)
Now hiring (1)
Obesity (93)
Opinion (24)
Ovarian cancer (28)
Pain (26)
Pancreatic cancer (30)
Parkinson's disease (43)
Partnered (2)
Patents (66)
Patient recruitment (52)
Peanut (15)
People (6631)
Pharmaceutical (7)
Pharmacy benefit managers (3)
Phase I (4121)
Phase II (6605)
Phase III (6222)
Pipeline (1773)
Policy (15)
Postmarket research (558)
Preclinical (1434)
Press Release (12)
Prostate cancer (34)
Psychedelics (5)
Radiopharmaceuticals (50)
Rare diseases (137)
Real estate (643)
Recruiting (9)
Regulatory (4547)
Reports (16)
Research institute (395)
Resumes & cover letters (17)
Rett syndrome (6)
RNA editing (3)
RSV (12)
Schizophrenia (42)
Series A (15)
Series B (18)
Service/supplier (5)
Sickle cell disease (13)
Special edition (9)
Spinal muscular atrophy (35)
Sponsored (3)
Startups (386)
Stomach cancer (6)
Supply chain (11)
Tariffs (7)
The Weekly (1)
Vaccines (176)
Venture capital (13)
Weight loss (67)
Women's health (13)
Date
Today (20)
Last 7 days (33)
Last 30 days (282)
Last 365 days (7054)
2026 (29)
2025 (7039)
2024 (7852)
2023 (12425)
2022 (25888)
2021 (10841)
2020 (9929)
2019 (8582)
2018 (6335)
2017 (5599)
2016 (5006)
2015 (6434)
2014 (4391)
2013 (3098)
2012 (3475)
2011 (3626)
2010 (3374)
Location
Africa (97)
Alabama (15)
Arizona (34)
Arkansas (1)
Asia (8447)
Australia (1261)
California (2410)
Canada (748)
China (220)
Colorado (125)
Connecticut (91)
Delaware (117)
Europe (19679)
Florida (321)
Georgia (64)
Idaho (9)
Illinois (130)
India (12)
Indiana (129)
Iowa (7)
Japan (96)
Kansas (21)
Kentucky (7)
Louisiana (9)
Maine (27)
Maryland (293)
Massachusetts (1467)
Michigan (58)
Minnesota (126)
Mississippi (1)
Missouri (21)
Montana (8)
Nebraska (5)
Nevada (24)
New Hampshire (12)
New Jersey (776)
New Mexico (2)
New York (688)
North Carolina (298)
North Dakota (1)
Northern California (1237)
Ohio (50)
Oklahoma (1)
Oregon (3)
Pennsylvania (596)
Rhode Island (2)
South America (192)
South Carolina (4)
Southern California (936)
Tennessee (25)
Texas (306)
United States (8363)
Utah (54)
Virginia (64)
Washington D.C. (6)
Washington State (192)
West Virginia (1)
Wisconsin (12)
141,314 Results for "26".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Outlook Therapeutics Announces New Employment Inducement Grants - December 26, 2025
December 29, 2025
·
1 min read
Press Releases
Chemed to Report Fourth-Quarter 2025 Earnings February 25, Related Conference Call to Be Held on February 26
January 5, 2026
·
1 min read
Press Releases
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - December 26, 2025
December 29, 2025
·
1 min read
Press Releases
DNA-encoded Library Market Size to Hit USD 2.6 Billion by 2034
November 20, 2025
·
1 min read
Press Releases
Immutep Quarterly Activities Report Q1 FY26
October 30, 2025
·
10 min read
Obesity
Lilly’s Retatrutide Scores Triple Trial Triumph With 26% Weight Loss, But New Safety Signal Emerges
Analysts were hoping for a safety profile similar to what was achieved in Phase II but an abnormal sense of touch, called dysesthesia, has emerged in the late-stage TRIUMPH-4 trial.
December 11, 2025
·
3 min read
·
Annalee Armstrong
Press Releases
Immuron Q1 FY26 YoY growth
October 13, 2025
·
4 min read
Press Releases
Propanc Biopharma Provides Corporate Update and Reports First Quarter 2025/26 Results
November 18, 2025
·
7 min read
Press Releases
Piramal Pharma Limited Announces Results for Q2 and H1 FY26
November 6, 2025
·
7 min read
Press Releases
Coloplast A/S - Financial Calendar 2025-26
October 1, 2025
·
1 min read
1 of 14,132
Next
